ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DOCS Dr. Martens Plc

54.95
-0.90 (-1.61%)
Last Updated: 11:16:07
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dr. Martens Plc LSE:DOCS London Ordinary Share GB00BL6NGV24 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -0.90 -1.61% 54.95 238,246 11:16:07
Bid Price Offer Price High Price Low Price Open Price
54.85 55.05 58.95 54.85 58.95
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Footwear-wholesale 877.1M 69.2M 0.0719 19.19 537.39M
Last Trade Time Trade Type Trade Size Trade Price Currency
11:22:20 O 12,656 55.00 GBX

Dr. Martens (DOCS) Latest News

Dr. Martens (DOCS) Discussions and Chat

Dr. Martens Forums and Chat

Date Time Title Posts
30/10/202412:08Dr. Martens838
22/4/202406:15Dr Martens - just mucking about (please ignore)11

Add a New Thread

Dr. Martens (DOCS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
11:22:2055.0012,6566,960.80O
11:16:0754.952614.29AT
11:16:0754.952614.29AT
11:16:0754.9516188.47AT
11:16:0754.90542297.56AT

Dr. Martens (DOCS) Top Chat Posts

Top Posts
Posted at 21/11/2024 08:20 by Dr. Martens Daily Update
Dr. Martens Plc is listed in the Footwear-wholesale sector of the London Stock Exchange with ticker DOCS. The last closing price for Dr. Martens was 55.85p.
Dr. Martens currently has 962,197,384 shares in issue. The market capitalisation of Dr. Martens is £1,327,832,390.
Dr. Martens has a price to earnings ratio (PE ratio) of 19.19.
This morning DOCS shares opened at 58.95p
Posted at 23/9/2024 07:48 by pireric
Should rename the company to Dog Martens in sympathy with the share price performance since IPO

Eric
Posted at 21/9/2024 13:16 by mr5k
it's the responsibility of the company secretary to issue the rns (which is also the fd in many companies). the mechanism for the issuance is first for the seller or buyer to notify the exchange and the company when a line has been crossed. if docs have not received the notification from the Permira and any other buyers that is not the company's fault.
Posted at 21/9/2024 12:21 by ih_538656
Dave, I would say SDG as a potential recovery play (much smaller size!) could be interesting - however their H1 outlook (16 October) may be dire.

Having aggressively rolled out physical space makes DOCS a more challenging situation. Their price point with cheaper non branded 'substitutes' available also a headwind.
Posted at 20/9/2024 14:55 by ih_538656
Tom, it's a global brand, although yes synonymous with Britain.

This is way wider than lower UK consumer confidence.

I mentioned at the time of the share buy back this was arguably la la land stuff, gearing up the balance sheet, and it may ultimately end with DOCS needing an equity raise That remains my view fwiw.
But no crystal ball as per.
Posted at 20/9/2024 14:22 by tomboyb
DOCs net debt going in the wrong direction -

And cash depreciating -

Overall results this year will therefore be very second-half weighted, particularly from a profit perspective.

Share price may well be very telling here -
Posted at 17/9/2024 21:41 by velocytongo
The Chinese are wearing knock offs which is why Docs no longer sell there.
Posted at 02/8/2024 14:32 by clocktower
Docs problems may soon extend well beyond the USA before very long. Like the market in general DOCS is on the back foot and heading towards 50p if there is any more bad news impo.

DYOR.
Posted at 16/7/2024 13:52 by mr5k
Burberry's issues are very different from Docs. High-end consumer brands have pushed prices beyond inflation for so long that many buyers have said enough. Also, BRBY was trying to elevate the brand to Dior and Versace levels and that has not worked.

I own a BRBY trench coat that cost me £120 25 years ago (as did many colleagues where I worked). That same coat now costs £1,500. Docs pricing is not out of whack with the price of other branded boots (Blundstones (a little more), Birkenstocks (more expensive) Russell and Bromley (even more expensive) and the price points are accessible.

In terms of Asian exposure, Japan and S Korea are performing well (atm) and they closed their operations in China. BRBY is particularly exposed to the latter in terms of direct sales and London, where the duty-free sales benefit was dumped by the Tories (another Brexit benefit).

Docs problems are in the US where the brand is less well established and the market is not as deep as management anticpated.
Posted at 17/4/2024 10:50 by itisonlymoney
darrin, thanks for the detail on the new ceo. Btw, does that look like the profile for a good fashion brand ceo? Big salary maybe. I have doubts. a senior director for apple retail - he's had lots of people around him to generate any success there. snr directors like to take all the credit if things go well, but out on their own, they often fail, so he's an unknown quantity at this point. does anyone here know how he did at wolf olins?

huckers, I've asked the same question. my instinct atm is that this fifth profit warning and the change of leadership (a necessary move) with an untested ceo who has apparently been on the board (as a non-exec rather than ops management) throughout this car crash, creates massive uncertainty on top of the forecast for much lower profits. there's nothing but shifting sand under the strategy and the forecasts, plus the global environment does not look good - major european war which it looks like russia will now win, and the prospect of a middle eastern war.

Docs has a high valuation based on its brand appeal but the retail market is not validating that appeal by buying the boots in huge numbers, so i think the share price has to reflect actual profit without a brand premium. that's my thinking and that leads me to guess that the share price is going steadily down for sometime now. i haven't got the confidence in that prediction to actually short the shares though, because there's no telling when a bid for the company could come. right now i'm watching. if the share price gets to 30p, i will almost certainly be a buyer.
Posted at 28/11/2022 14:32 by essentialinvestor
As the DOCS share price is given to large % moves in either direction, there are likely
to be ample trading opportunities for those astute/lucky enough to catch some
of those.
Dr. Martens share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock